🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to evaluate the pharmacokinetics and safety of SHR6390 at do...
Status
Completed
Location
Phase I Clinical Research Center
Start Date
2019-06-13
Trial ID
NCT05354336
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
This is an prospective, single-center, single-arm, Simon's two-stage design...
Status
Unknown
Location
Sixth Affiliated Hospital, Sun Yat-sen University
Start Date
2022-07-20
Trial ID
NCT05480280
Treatments Being Tested
Based on different HR status, we explored the efficacy and safety of Pyroti...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-05-20
Trial ID
NCT05328440
Treatments Being Tested
SHR6390 is a small molecular,oral potent, selective CDK4/6 inhibitor. The p...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2016-01
Trial ID
NCT02671513
Treatments Being Tested
SHR6390 is a small molecular, oral potent, selective CDK4/6 inhibitor. The ...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2016-03-03
Trial ID
NCT02684266
Treatments Being Tested
This is a single-center, single-arm phase Ib / II clinical trial, which was...
Status
Unknown
Location
Cancer Center of Sun-Yat Sen University (CCSYSU)
Start Date
2023-07-01
Trial ID
NCT05952128
Treatments Being Tested
This is a randomized, controlled, open-label, phase II study to explore the...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-07-26
Trial ID
NCT05949541
The aim of the study is to assess the safety and tolerability of SHR6390 co...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-07-27
Trial ID
NCT03480256
Treatments Being Tested
The study is being conducted to evaluate the efficacy, safety and tolerabil...
Status
Unknown
Location
Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University
Start Date
2019-09-30
Trial ID
NCT04095390
Treatments Being Tested